Compare WNEB & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WNEB | STXS |
|---|---|---|
| Founded | 1853 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.2M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | WNEB | STXS |
|---|---|---|
| Price | $12.62 | $2.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $11.00 | $4.00 |
| AVG Volume (30 Days) | 54.1K | ★ 409.8K |
| Earning Date | 01-27-2026 | 11-11-2025 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ 27.15 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $79,080,000.00 | $30,075,000.00 |
| Revenue This Year | N/A | $24.21 |
| Revenue Next Year | $7.48 | $29.83 |
| P/E Ratio | $19.21 | ★ N/A |
| Revenue Growth | 9.08 | ★ 19.62 |
| 52 Week Low | $7.63 | $1.54 |
| 52 Week High | $13.95 | $3.59 |
| Indicator | WNEB | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 41.72 |
| Support Level | $13.20 | $2.25 |
| Resistance Level | $13.51 | $2.48 |
| Average True Range (ATR) | 0.34 | 0.09 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 1.79 | 15.25 |
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.